SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 01/01/2018 | 3. Issuer Name and Ticker or Trading Symbol BOSTON SCIENTIFIC CORP [ BSX ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 92,531(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Deferred Stock Units | (2) | 02/23/2020(2) | Common Stock | 6,346(3) | (4) | D | |
Deferred Stock Units | (5) | 02/24/2019(5) | Common Stock | 5,276(6) | (4) | D | |
Deferred Stock Units | (7) | 02/28/2018(7) | Common Stock | 9,337(8) | (4) | D | |
Deferred Stock Units | (9) | 02/28/2022(9) | Common Stock | 8,146 | (4) | D | |
Deferred Stock Units | (10) | 10/27/2019(10) | Common Stock | 3,052(11) | (4) | D | |
Deferred Stock Units | (12) | 10/29/2018(12) | Common Stock | 2,545(13) | (4) | D | |
Deferred Stock Units | (14) | 12/01/2020(14) | Common Stock | 6,075(15) | (4) | D | |
Stock Option (Right to Buy) | (16) | 02/24/2024 | Common Stock | 34,500 | 13.08 | D | |
Stock Option (Right to Buy) | (17) | 02/23/2025 | Common Stock | 32,003 | 16.31 | D | |
Stock Option (Right to Buy) | (18) | 12/01/2025 | Common Stock | 30,637 | 18.52 | D | |
Stock Option (Right to Buy) | (19) | 02/28/2027 | Common Stock | 28,860 | 24.55 | D |
Explanation of Responses: |
1. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. |
2. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
3. This amount represents the unvested portion of DSUs awarded on February 23, 2015, which will continue to vest in three remaining installments on the anniversary of the date of grant. |
4. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
5. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. |
6. This amount represents the unvested portion of DSUs awarded on February 24, 2014, which will continue to vest in two remaining installments on the anniversary of the date of grant. |
7. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. |
8. This amount represents the unvested portion of DSUs awarded on February 28, 2013, which will continue to vest in one remaining installment on the anniversary of the date of grant. |
9. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
10. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 27, 2015, the first anniversary of the date of grant. |
11. This amount represents the unvested portion of DSUs awarded on October 27, 2014, which will continue to vest in two remaining installments on the anniversary of the date of grant. |
12. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 29, 2014, the first anniversary of the date of grant. |
13. This amount represents the unvested portion of DSUs awarded on October 29, 2013, which will continue to vest in one remaining installment on the anniversary of the date of grant. |
14. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant. |
15. This amount represents the unvested portion of DSUs awarded on December 1, 2015, which will continue to vest in three remaining installments on the anniversary of the date of grant. |
16. Grant to the reporting person of an option to purchase a 34,500 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. |
17. Grant to the reporting person of an option to purchase a 32,003 shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
18. Grant to the reporting person of an option to purchase a 30,637 shares of common stock vesting in four equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant. |
19. Grant to the reporting person of an option to purchase a 28,860 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
Remarks: |
wangpoa.txt |
/s/ Vance R. Brown, Attorney-in-fact | 01/08/2018 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |